Skip to main content
Fig. 10 | Journal of Translational Medicine

Fig. 10

From: Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib

Fig. 10

Downregulation of PADI2 combinated with Olaparib inhibited epithelial-mesenchymal transition and STAT3 of tumor in vivo. a Representative IHC staining showed the expression of PADI2 E-cadherin, Vimentin and phospho-STAT3 in tumor issues (× 200 magnification, scale:100 μm). b Quantification of the expression of PADI2 E-cadherin, Vimentin and phospho-STAT3. *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us